July 2026 FDA Recall Lidolog Kit by Asclemed Usa Inc.
D-0713-2026 - Labeling
This Class III drug recall was voluntarily initiated by Asclemed Usa Inc. on July 15, 2026 for the product Lidolog Kit. The FDA reported the reason for recall as labeling. The product was distributed in Within U.S. - Tennessee and the recall is currently ongoing.
Recall Number: D-0713-2026
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
07-15-2026
07-29-2026
18 kits
Recall Profile & Regulatory Data
Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Ongoing
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Asclemed USA Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Within U.S. - Tennessee
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose, Single use Only, Rx Only, Distributed by: Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 76420-760-01.
Batch or Lot Expiration Information
Lot# Lot: 070126X1, Exp. 12/31/2027.
